Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS market map / Vertical sector platforms / Healthcare and life sciences platforms / Laboratory and diagnostics informatics platforms

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Laboratory and diagnostics informatics platforms

Subscription platforms for clinical and research laboratories and diagnostics manufacturers: LIS/LIMS, molecular and specialty assay data, sample and biobank management, instrument integration, QC and lab analytics. Carved out of the health-system clinical niche so that laboratory informatics is counted once, for hospital labs, reference/contract labs and diagnostics manufacturers. Excludes general hospital financial ERP.

Market size
$1.6B
$1.6B ($1.2B–$2.2B) · 2026 · Top-down
Growth
+11.5%
$2.8B by 2031
Attractiveness
— /100
for B2B sellers
Evidence
Low confidence
2 sources · Top-down
Level
Niche
Segmented by
Customer type
Buyers
Lab director / VP Lab Medicine, diagnostics operations leader, head of diagnostics R&D and quality
Buying centre
Lab operations plus IT plus quality/regulatory; procurement run with clinical or manufacturing leadership; often validated through a formal RFP
Buying triggers
  • Launch of a new assay or test menu
  • Deployment of lab automation and robotics
  • Accreditation, CLIA/regulatory compliance refresh
  • Consolidation of a lab network or diagnostics M&A
  • Instrument data and AI analytics programmes
Pains
  • Fragmented instrument and LIS data
  • Sample tracking and chain-of-custody errors
  • Turnaround-time and workflow variability
  • Compliance, audit and accreditation burden
  • Interoperability with EHR, public health and research systems
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—

How this was sized

$1.6B ($1.2B–$2.2B) · 2026 · Top-down

In-scope 2026 pool ~$19.8bn (see niche 1 arithmetic from [7] and [10]). Niche = 8% of pool (assumption, Low confidence) = $1.6bn; range 6-11% = $1.2-2.2bn. Forecast 2031 at 11.52% [10] = $2.8bn; at 19.4% [7] = $3.9bn. No source gives a laboratory-specific figure; the share is an analyst assumption and the widest uncertainty in the set.

Alongside it in Healthcare and life sciences platforms

// Sell into Laboratory and diagnostics informatics platforms

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.